Open Access234 COMBINATION THERAPY WITH SUBEROYLANILIDE HYDROXAMIC ACID AND BORTEZOMIB INDUCES HISTONE ACETYLATION AND PROTEIN UBIQUITINATION SYNERGISTICALLY IN RENAL CANCER CELLS
Author(s) -
Akinori Sato,
Takako Asano,
Akio Horiguchi,
Keiichi Ito,
Makoto Sumitomo,
Tomohiko Asano
Publication year - 2011
Publication title -
the journal of urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.402
H-Index - 256
eISSN - 1527-3792
pISSN - 0022-5347
DOI - 10.1016/j.juro.2011.02.303
Subject(s) - acetylation , bortezomib , medicine , cancer research , histone deacetylase , histone , cancer , proteasome , cyclin d1 , ubiquitin , cancer cell , proteasome inhibitor , hydroxamic acid , histone deacetylase inhibitor , pharmacology , cell cycle , multiple myeloma , biochemistry , chemistry , dna , stereochemistry , gene
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom